Literature DB >> 31833786

Self-Monitoring of Blood Glucose Requirements with the Use of Intermittently Scanned Continuous Glucose Monitoring.

Monika Reddy1, Nick Oliver1.   

Abstract

Current intermittently scanned continuous glucose monitoring (isCGM) devices do not allow calibration and require confirmatory self-monitored blood glucose (SMBG) under specific defined conditions. The overall time spent in an SMBG-indicated state while using isCGM has not been reported in the existing literature. We present the time spent in an SMBG-indicated state and the daily number of transitions to an SMBG-indicated state during isCGM use in a high-risk cohort of adults with type 1 diabetes. This is a post hoc analysis of participants randomized to isCGM as part of a clinical study. The percentage of values meeting one or more of the criteria for SMBG testing (hours per day) and the number of transitions to an SMBG-indicated state per day were calculated according to the manufacturer's label in the United Kingdom. Complete data sets for 20 participants on isCGM for 8 weeks were included in the analysis. Participants spent a mean (SD) of 5.61 (1.81) h/day in an SMBG-indicated state and there were 5.43 (1.42) transitions to an SMBG-indicated state per day while using isCGM. These findings have important implications for cost-effectiveness and for decision-making around insulin dose calculations and driving. Our findings emphasize the need for continued SMBG testing among people at high risk of hypoglycemia who use isCGM. Cost-effectiveness analyses for isCGM may require revision.

Entities:  

Keywords:  Flash glucose monitoring; Hypoglycemia; Intermittently scanned continuous glucose monitoring; Type 1 diabetes

Mesh:

Substances:

Year:  2020        PMID: 31833786      PMCID: PMC7047107          DOI: 10.1089/dia.2019.0369

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  7 in total

1.  Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.

Authors:  Jan Bolinder; Ramiro Antuna; Petronella Geelhoed-Duijvestijn; Jens Kröger; Raimund Weitgasser
Journal:  Lancet       Date:  2016-09-12       Impact factor: 79.321

2.  Efficacy of Intermittently Scanned Continuous Glucose Monitoring in the Prevention of Recurrent Severe Hypoglycemia.

Authors:  Timothy M E Davis; Penny Dwyer; Michelle England; P Gerry Fegan; Wendy A Davis
Journal:  Diabetes Technol Ther       Date:  2020-05       Impact factor: 6.118

3.  Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment.

Authors:  Richard Hellmund; Raimund Weitgasser; Deirdre Blissett
Journal:  Diabetes Res Clin Pract       Date:  2018-02-02       Impact factor: 5.602

4.  Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden.

Authors:  Peter Moström; Elsa Ahlén; Henrik Imberg; Per-Olof Hansson; Marcus Lind
Journal:  BMJ Open Diabetes Res Care       Date:  2017-04-06

5.  A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia.

Authors:  M Reddy; N Jugnee; A El Laboudi; E Spanudakis; S Anantharaja; N Oliver
Journal:  Diabet Med       Date:  2017-12-29       Impact factor: 4.359

6.  Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes.

Authors:  Victoria Tyndall; Roland H Stimson; Nicola N Zammitt; Stuart A Ritchie; John A McKnight; Anna R Dover; Fraser W Gibb
Journal:  Diabetologia       Date:  2019-06-09       Impact factor: 10.122

Review 7.  Cost-effectiveness Analysis of a Flash Glucose Monitoring System for Patients with Type 1 Diabetes Receiving Intensive Insulin Treatment in Sweden.

Authors:  S Pinar Bilir; Richard Hellmund; Beth Wehler; Huimin Li; Julie Munakata; Mark Lamotte
Journal:  Eur Endocrinol       Date:  2018-09-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.